Suppr超能文献

对患有巨食管且血清学结果为阴性或不确定的恰加斯病患者进行分子诊断。

Molecular diagnosis of Chagas disease in patients with megaesophagus exhibiting negative or inconclusive serological results.

作者信息

Batista Angelica Martins, Pavan Tycha Bianca Sabaini, de Almeida Eros Antonio, de Alcantara Daniel Maximo Corrêa, Andrade Paula Durante, Martins Luiz Cláudio, Wanderley Jamiro da Silva, Costa Sandra Cecília Botelho, Marcon Gláucia Elisete Barbosa

机构信息

Center of Biological and Health Sciences, Estácio de Sá University, Rio de Janeiro, RJ, Brazil.

Advanced Public Health Laboratory, Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, BA, Brazil.

出版信息

Front Parasitol. 2025 Aug 13;4:1622149. doi: 10.3389/fpara.2025.1622149. eCollection 2025.

Abstract

Chagasic megaesophagus is a relatively uncommon clinical manifestation in individuals with chronic Chagas disease (CD), and it has not been extensively documented in literature. However, individuals may exhibit negative or inconclusive serology for CD. This study aimed to assess the performance of molecular diagnostics for CD in participants with these conditions. This was a prospective cohort study that included 26 participants with negative or inconclusive conventional CD serology (Group I), 33 participants with positive CD serology and megaesophagus (Group II), and 10 participants with negative serology and no CD epidemiological history (Group III). Blood samples were collected for serological tests (ELISA and IFAT), blood cultures, and molecular tests like nested PCR (nPCR) targeting Sat-DNA and kDNA, as well as quantitative PCR (qPCR) of . Statistical analyses applying the Composite Reference Standard (CRS), showed that diagnosis by Sat-DNA nPCR had a sensitivity of 95% (95% CI: 82%-99%), a specificity of 81% (95% CI: 64%-93%), an accuracy of 88%. When considering a positive result from at least one molecular test, 20 out of 26 participants with megaesophagus and negative or inconclusive conventional serology were identified (76.9%). This study reinforce the greater detection capacity of Sat-DNA nPCR compared to the diagnostic methods tested. This emphasizes the importance of employing molecular diagnosis to clarify the etiology in megaesophagus cases.

摘要

查加斯病性巨食管是慢性查加斯病(CD)患者中相对不常见的临床表现,在文献中尚未有广泛记载。然而,患者的CD血清学检查可能呈阴性或结果不确定。本研究旨在评估分子诊断方法对患有这些情况的参与者中CD的诊断效能。这是一项前瞻性队列研究,纳入了26名传统CD血清学检查呈阴性或结果不确定的参与者(第一组)、33名CD血清学检查呈阳性且患有巨食管的参与者(第二组)以及10名血清学检查呈阴性且无CD流行病学史的参与者(第三组)。采集血样进行血清学检测(酶联免疫吸附测定和间接荧光抗体试验)、血培养以及分子检测,如针对卫星DNA和动基体DNA的巢式聚合酶链反应(nPCR),以及[此处原文缺失部分内容]的定量聚合酶链反应(qPCR)。应用综合参考标准(CRS)进行的统计分析表明,通过卫星DNA nPCR进行诊断的灵敏度为95%(95%置信区间:82% - 99%),特异性为81%(95%置信区间:64% - 93%),准确率为88%。当考虑至少一项分子检测结果为阳性时,在26名患有巨食管且传统血清学检查呈阴性或结果不确定的参与者中,有20名被确诊(76.9%)。本研究证实,与所测试的诊断方法相比,卫星DNA nPCR具有更强的检测能力。这强调了采用分子诊断来明确巨食管病例病因的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce07/12380845/3dec69c9b72c/fpara-04-1622149-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验